Literature DB >> 23770280

Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.

Azeem S Kaka1, Bhavna Kumar, Pawan Kumar, Paul E Wakely, Claudia M Kirsch, Matthew O Old, Enver Ozer, Amit Agrawal, Ricardo E Carrau, David E Schuller, Farzan Siddiqui, Theodoros N Teknos.   

Abstract

OBJECTIVE: Although the majority of human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinomas have a favorable prognosis, we search for markers of poor prognosis by carefully examining a subset of highly aggressive cases. STUDY
DESIGN: Seven patients with HPV-positive oropharyngeal cancer who presented with non-pulmonary distant metastasis or developed distant metastasis posttreatment were identified. Eight control cases were chosen which responded well to treatment. Pathologic and radiologic studies were reviewed and compared.
RESULTS: Two cases displayed a small cell carcinoma (SmCC) component upon pathologic review. Biomarker analysis revealed lower expression of NOTCH1 in the aggressive cohort in comparison to controls (P = .04). Cases showed a predominance of clustering of lymph nodes, extracapsular spread, and central tumor necrosis.
CONCLUSION: Although most HPV-related oropharyngeal cancers display a positive prognosis, it is evident that there is a subset, which behaves more aggressively. This early investigation identifies pathologic and radiologic features that may help to predict this behavior.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23770280      PMCID: PMC3748144          DOI: 10.1016/j.oooo.2013.04.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  25 in total

1.  HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.

Authors:  Stefan Kraft; William C Faquin; Jeffrey F Krane
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

2.  Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.

Authors:  Shahnaz Begum; Dengfeng Cao; Maura Gillison; Marianna Zahurak; William H Westra
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

Review 3.  Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis.

Authors:  P M Som
Journal:  AJR Am J Roentgenol       Date:  1992-05       Impact factor: 3.959

4.  Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.

Authors:  Claudio Talora; Samantha Cialfi; Oreste Segatto; Stefania Morrone; John Kim Choi; Luigi Frati; Gian Paolo Dotto; Alberto Gulino; Isabella Screpanti
Journal:  Exp Cell Res       Date:  2005-05-01       Impact factor: 3.905

Review 5.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Authors:  Maura L Gillison
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

Review 6.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

7.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

8.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

Review 9.  Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.

Authors:  Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Oncologist       Date:  2007-05

10.  Extracapsular spread in the clinically negative neck (N0): implications and outcome.

Authors:  A Alvi; J T Johnson
Journal:  Otolaryngol Head Neck Surg       Date:  1996-01       Impact factor: 5.591

View more
  12 in total

1.  Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Authors:  T J Rath; S Narayanan; M A Hughes; R L Ferris; S I Chiosea; B F Branstetter
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

Review 2.  Molecular prognostic indicators in HPV-positive oropharyngeal cancer: an updated review.

Authors:  Gregoire B Morand; Alina Diaconescu; Iman Ibrahim; Genevieve Lamarche; Juliana S Ruas; Jacqueline Dalfen; Michael P Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Clin Exp Metastasis       Date:  2022-01-27       Impact factor: 5.150

3.  Predictors of Outcome after (Chemo)Radiotherapy for Node-Positive Oropharyngeal Cancer: The Role of Functional MRI.

Authors:  Pasqualina D'Urso; Alessia Farneti; Laura Marucci; Simona Marzi; Francesca Piludu; Antonello Vidiri; Giuseppe Sanguineti
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

4.  Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes.

Authors:  P Sinha; W T Thorstad; B Nussenbaum; B H Haughey; D R Adkins; D Kallogjeri; J S Lewis
Journal:  Oral Oncol       Date:  2013-11-06       Impact factor: 5.337

5.  Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog.

Authors:  Bhavna Kumar; Arti Yadav; James C Lang; Theodoros N Teknos; Pawan Kumar
Journal:  Genes Cancer       Date:  2015-03

6.  High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.

Authors:  Bhavna Kumar; Nicole V Brown; Benjamin J Swanson; Alessandra C Schmitt; Matthew Old; Enver Ozer; Amit Agrawal; David E Schuller; Theodoros N Teknos; Pawan Kumar
Journal:  Oncotarget       Date:  2016-04-05

7.  Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status.

Authors:  Bhavna Kumar; Arti Yadav; Nicole V Brown; Songzhu Zhao; Michael J Cipolla; Paul E Wakely; Alessandra C Schmitt; Robert A Baiocchi; Theodoros N Teknos; Matthew Old; Pawan Kumar
Journal:  Oncotarget       Date:  2017-02-28

8.  Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Authors:  Boeun Lee; Young Jun Choi; Seon Ok Kim; Yoon Se Lee; Jung Yong Hong; Jung Hwan Baek; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2019-08       Impact factor: 3.500

9.  Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer.

Authors:  Houda Bahig; Clifton D Fuller; Aparna Mitra; Kyoko Yoshida-Court; Travis Solley; Sweet Ping Ng; Ibrahim Abu-Gheida; Baher Elgohari; Andrea Delgado; David I Rosenthal; Adam S Garden; Steven J Frank; Jay P Reddy; Lauren Colbert; Ann Klopp
Journal:  Clin Transl Radiat Oncol       Date:  2020-11-18

10.  A MicroRNA Expression Signature as Prognostic Marker for Oropharyngeal Squamous Cell Carcinoma.

Authors:  Xinyi Liu; Ping Liu; Rebecca D Chernock; Zhenming Yang; Krystle A Lang Kuhs; James S Lewis; Jingqin Luo; Hua Li; Hiram A Gay; Wade L Thorstad; Xiaowei Wang
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.